#11 weekly recap
From risk-on to risk off and a shaky resilience of biotechs.
Summary
Total 19 trades:
2 were round trades (bought and sold)
7 were closing trades from the prior weeks
10 were new buys to start a new or add to an existing position
Endowment’s weekly trading profit target reached by 80%, monthly - by 101%. Closed an old & expired call option from 2025, whose premium paid converted into a loss, decreasing weekly profit by 20%.
As a paid subscriber, you will receive daily updates every morning on the stocks I’m buying, selling, or keeping a close eye on to start your trading day. During the day, we keep the paid subscriber-only chat active, sharing ideas and insights or discussing market events and various other investment-related topics.
Key highlights
It was a week of extremes. Monday started with an accelerating risk-on energy, which, unfortunately, was short-lived and soon lost its steam. The next few days were wandering without direction, and on Friday, it all went bust, completely switching to risk-off mode. Especially in the least expected area of biotechs, which held resilient to the negative market mood for quite a long time.
